Home / FGF basic/FGF2/bFGF / Human FGF basic/FGF2/bFGF Quantikine HS ELISA Kit

Human FGF basic/FGF2/bFGF Quantikine HS ELISA Kit

Catalog #: HSFB00D
17 Citations Datasheet / COA / SDS
Catalog # Availability Size / Price Qty
PHSFB00D
SSFB00D
HSFB00D
Control Products Available
QC41: Quantikine Immunoassay Control Group 10
Human FGF basic ELISA Standard Curve
2 Images
Product Details
Citations (17)
FAQs
Supplemental Products
Reviews
Summary Recovery Linearity Data Examples Product Datasheets Preparation and Storage Background Related Research Areas

Human FGF basic/FGF2/bFGF Quantikine HS ELISA Kit Summary

Assay Length
5.5 hours
Sample Type & Volume Required Per Well
Serum (100 uL), EDTA Plasma (100 uL), Citrate Plasma (100 uL), Urine (100 uL)
Sensitivity
0.07 pg/mL
Assay Range
0.3 - 20 pg/mL (Serum, EDTA Plasma, Citrate Plasma, Urine)
Specificity
Natural and recombinant human FGF basic
Cross-reactivity
< 0.5% cross-reactivity observed with available related molecules.Cross-species reactivity not tested.
Interference
No significant interference observed with available related molecules.

Product Summary

The Quantikine HS Human FGF basic Immunoassay kit is a 5.5 hour solid phase ELISA designed to measure FGF basic levels in serum, plasma, and urine. It contains E. coli-expressed recombinant human FGF basic and antibodies raised against the recombinant factor. It has been shown to quantitate recombinant human FGF basic accurately. Results obtained using natural human FGF basic showed linear curves that were parallel to the standard curves obtained using the Quantikine HS kit standards. These results indicate that this kit can be used to determine relative mass values for natural human FGF basic.

Recovery

The recovery of FGF basic spiked to three different levels throughout the range of the assay in various matrices was evaluated.

Sample Type Average % Recovery Range %
Citrate Plasma (n=4) 97 83-118
EDTA Plasma (n=4) 99 85-109
Serum (n=4) 100 88-116
Urine (n=4) 109 100-120

Linearity

To assess the linearity of the assay, the following biological samples spiked with high concentrations of FGF basic were diluted with Calibrator Diluent and assayed.
Human FGF basic ELISA Linearity

Scientific Data

N/A Human FGF basic ELISA Standard Curve View Larger

Human FGF basic ELISA Standard Curve

Product Datasheets

You must select a language.

x
Product Datasheet
COA
SDS

Preparation and Storage

Shipping
The product is shipped at ambient temperature. Upon receipt, store it immediately at the temperature recommended below.
Storage
Store the unopened product at 2 - 8 °C. Do not use past expiration date.

Background: FGF basic/FGF2/bFGF

FGF basic/FGF2/bFGF is a growth factor that functions in angiogenesis, wound healing, tissue repair, learning and memory, and the morphogenesis of heart, bone, and brain. It is upregulated in response to inflammatory stimuli and in many tumors. FGF basic/FGF2/bFGF binds to FGFR1c and 2c. Its bioactivity is modulated by a number of other binding partners including heparin, Integrin alpha V beta 3, soluble FGFR1, FGF-BP, free gangliosides, Thrombospondin, Pentraxin 3/TSG-14, Fibrinogen, alpha 2-Macroglobulin, PDGF, and CXCL4/PF4. These molecules act as cellular coreceptors or adhesion partners, extracellular matrix decoys or reservoirs, and soluble scavengers or chaperones. In particular, the interaction of FGF basic/FGF2/bFGF with cell surface heparan sulfate proteoglycans (HSPG) is required for the binding and activation of FGF receptors.

Long Name:
Fibroblast Growth Factor basic
Entrez Gene IDs:
2247 (Human); 14173 (Mouse); 281161 (Bovine); 403857 (Canine); 100033955 (Equine)
Alternate Names:
basic fibroblast growth factor bFGF; Basic fibroblast growth factor; bFGF; FGF basic; FGF2; FGF-2; FGFBprostatropin; fibroblast growth factor 2 (basic); HBGF-2; heparin-binding growth factor 2; Prostatropin

Citations for Human FGF basic/FGF2/bFGF Quantikine HS ELISA Kit

R&D Systems personnel manually curate a database that contains references using R&D Systems products. The data collected includes not only links to publications in PubMed, but also provides information about sample types, species, and experimental conditions.

17 Citations: Showing 1 - 10
Filter your results:

Filter by:

  1. miR-709 exerts an angiogenic effect through a FGF2 upregulation induced by a GSK3B downregulation
    Authors: Ueno, K;Kurazumi, H;Suzuki, R;Yanagihara, M;Mizoguchi, T;Harada, T;Morikage, N;Hamano, K;
    Scientific reports
    Species: Human
    Sample Types: Cell Culture Supernates
  2. Angiogenic factors measured in aspirated placental tissue between the 10?+?6 and 18?+?3 weeks of gestation
    Authors: J Sikovanyec, M Vincze, I Földesi, G Németh, Z Kozinszky
    Reproductive biology, 2021-11-16;21(4):100572.
    Species: Human
    Sample Types: Tissue Homogenates
  3. Dose selection trial of metronomic oral vinorelbine monotherapy in patients with metastatic cancer: a hellenic cooperative oncology group clinical translational study.
    Authors: Briasoulis, Evangelo, Aravantinos, Gerasimo, Kouvatseas, George, Pappas, Periklis, Biziota, Eirini, Sainis, Ioannis, Makatsoris, Thomas, Varthalitis, Ioannis, Xanthakis, Ioannis, Vassias, Antonios, Klouvas, George, Boukovinas, Ioannis, Fountzilas, George, Syrigos, Kostanti, Kalofonos, Haralamb, Samantas, Epaminon
    BMC Cancer, 2013-05-29;13(1):263.
    Species: Human
    Sample Types: Plasma
  4. Plasma biomarkers as predictors of outcome in patients with advanced hepatocellular carcinoma.
    Authors: Llovet JM, Pena CE, Lathia CD, Shan M, Meinhardt G, Bruix J, Pallota MG, Zarba JJ, Boyer M, Riordan S, Strickland A, Tebbutt N, Thomson B, Borbath I, De Greve J, Van Laethem J-, Van Steenbergen W, Van Vlierberghe H, Barrios C, Cosme de Oliveira A, Kotzev I, Takov D, Tchernev K, Burak K, Ma M, Metrakos P, Olweny C, Sherman M, Gamargo Garate C, Martinez-Castillo J, Beaugrand M, Bennouna J, Blanc J-, Bronowicki J-, Degos F, Dominguez S, Grange J-, Hillon P, Raoul J-, Seitz J-, Blum H, Buggisch P, Caspary W, Dollinger M, Gerken G, Goke B, Gregor M, Greten T, Haussinger D, Hilgard P, Scherübl J, Scheulen M, Schmid R, Spengler U, Wiest R, Zeuzem S, Arvanitakis C, Germanidis G, Katsos I, Figer A, Stemmer S, Amadori D, Bolondi L, Cognetti F, Craxi A, Farinati F, Gridelli C, Martoni A, Mazzaferro V, Porta C, Ricci S, Sangiovanni A, Santoro A, Trevisani F, Cisnero Garza LE, Gane E, O'Donnell A, Leon J, Lozano A, Jassem J, Rydzewska G, Szawlowski A, Tomczak P, Badulescu F, Miron L, Kubyshkin V, Bruix J, Forner A, Bustamante Schneider J, Diago M, Montero Alvarez JL, Pascual S, Ruíz del Arbol L, Sangro B, Solá R, Tabernero J, Muellhaupt B, Roth A, Jeffry Evans TR, Falk S, Meyer T, Reeves H, Ross P, Befeler A, Boyer T, Britten C, Byrne T, Garcia-Tsao G, Gold P, Goldenberg A, Heuman D, Kennedy P, Koch A, Llovet JM, Marrero J, Schilsky M, Schwartz J, Schwartz M
    Clin. Cancer Res., 2012-02-28;18(8):2290-300.
    Species: Human
    Sample Types: Plasma
  5. Local cytokine concentrations and oxygen pressure are related to maturation of the collateral circulation in humans.
    Authors: Schirmer SH, van Royen N, Moerland PD, Fledderus JO, Henriques JP, van der Schaaf RJ, Vis MM, Baan J, Koch KT, Horrevoets AJ, Hoefer IE, Piek JJ
    J. Am. Coll. Cardiol., 2009-06-09;53(23):2141-7.
    Species: Human
    Sample Types: Plasma
  6. Oncogenic and angiogenic growth factors accumulate during routine storage of apheresis platelet concentrates.
    Authors: Kanter J, Khan SY, Kelher M, Gore L, Silliman CC
    Clin. Cancer Res., 2008-06-15;14(12):3942-7.
    Species: Human
    Sample Types: Platelet Poor Plasma
  7. Dedicated epithelial recipient cells determine pigmentation patterns.
    Authors: Weiner L, Han R, Scicchitano BM, Li J, Hasegawa K, Grossi M, Lee D, Brissette JL
    Cell, 2007-09-07;130(5):932-42.
    Species: Mouse
    Sample Types: Cell Culture Supernates
  8. Serum concentrations of angiogenic cytokines in Waldenstrom macroglobulinaemia: the ration of angiopoietin-1 to angiopoietin-2 and angiogenin correlate with disease severity.
    Authors: Anagnostopoulos A, Eleftherakis-Papaiakovou V, Kastritis E, Tsionos K, Bamias A, Meletis J, Dimopoulos MA, Terpos E
    Br. J. Haematol., 2007-06-01;137(6):560-8.
    Species: Human
    Sample Types: Serum
  9. Fibroblast growth factor-2 expression is altered in lambs with increased pulmonary blood flow and pulmonary hypertension.
    Authors: Wedgwood S, Devol JM, Grobe A, Benavidez E, Azakie A, Fineman JR, Black SM
    Pediatr. Res., 2007-01-01;61(1):32-6.
    Species: Ovine
    Sample Types: Serum
  10. Endostatin variations in childhood acute lymphoblastic leukaemia--comparison with basic fibroblast growth factor and vascular endothelial growth factor.
    Authors: Schneider P, Vasse M, Corbiere C, Legrand E, Marie-Cardine A, Boquet C, Cazin L, Vannier JP
    Leuk. Res., 2006-09-29;31(5):629-38.
    Species: Human
    Sample Types: Plasma
  11. Phase II study of recombinant human endostatin in patients with advanced neuroendocrine tumors.
    Authors: Kulke MH, Bergsland EK, Ryan DP, Enzinger PC, Lynch TJ, Zhu AX, Meyerhardt JA, Heymach JV, Fogler WE, Sidor C, Michelini A, Kinsella K, Venook AP, Fuchs CS
    J. Clin. Oncol., 2006-08-01;24(22):3555-61.
    Species: Human
    Sample Types: Urine
  12. Elevated levels of fibroblast growth factor-2 in serum from women with endometriosis.
    Authors: Bourlev V, Larsson A, Olovsson M
    Am. J. Obstet. Gynecol., 2006-03-01;194(3):755-9.
    Species: Human
    Sample Types: Peritoneal Fluid
  13. Phase I clinical and pharmacokinetic study of PTK/ZK, a multiple VEGF receptor inhibitor, in patients with liver metastases from solid tumours.
    Authors: Mross K, Drevs J, Muller M, Medinger M, Marme D, Hennig J, Morgan B, Lebwohl D, Masson E, Ho YY, Gunther C, Laurent D, Unger C
    Eur. J. Cancer, 2005-06-01;41(9):1291-9.
    Species: Human
    Sample Types: Plasma
  14. Platelet concentrates: effects of calcium and thrombin on endothelial cell proliferation and growth factor release.
    Authors: Lacoste E, Martineau I, Gagnon G
    J. Periodontol., 2003-10-01;74(10):1498-507.
    Species: Human
    Sample Types: Cell Culture Supernates
  15. Inhibition of growth and metastasis of orthotopic human prostate cancer in athymic mice by combination therapy with pegylated interferon-alpha-2b and docetaxel.
    Authors: Huang SF, t?DüÝ ˆ!Û, Kim SJ, Ž˜™ ¢§r«C, Lee AT, Karashima T, Bucana C, Kedar D, Sweeney P, Mian B, Fan D, Shepherd D, Fidler IJ, Dinney CP, Killion JJ
    beta ¨ïې›Jyþ¢×677SªµÛ T¹Vñ¥óÊøhÍŸì5Û, 2002-10-15;62(20):5720-6.
    Species: Mouse
    Sample Types: Serum
  16. Targeted disruption of fibroblast growth factor receptor-1 blocks maturation of visceral endoderm and cavitation in mouse embryoid bodies.
    Authors: Esner M, D†­ÃÅê†Ò, Pachernik J, Hampl A, Dvorak P
    Îζ)Š4wJ]¾b.ŠKd•ÿ¶fäMò&¨k³, 2002-09-01;46(6):817-25.
    Species: Bovine
    Sample Types: Serum
  17. High urine concentrations of basic fibroblast growth factor in dogs with bladder cancer.
    Authors: Allen DK, Waters DJ, Knapp DW, Kuczek T
    J. Vet. Intern. Med., 1996-07-01;10(4):231-4.
    Species: Canine
    Sample Types: Urine, Whole Cells

FAQs

No product specific FAQs exist for this product, however you may

View all ELISA FAQs
Loading...

Reviews for Human FGF basic/FGF2/bFGF Quantikine HS ELISA Kit

There are currently no reviews for this product. Be the first to review Human FGF basic/FGF2/bFGF Quantikine HS ELISA Kit and earn rewards!

Have you used Human FGF basic/FGF2/bFGF Quantikine HS ELISA Kit?

Submit a review and receive an Amazon gift card.

$25/€18/£15/$25CAN/¥75 Yuan/¥2500 Yen for a review with an image

$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image

Submit a Review